Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Safety profile of treatment in diabetic peripheral neuropathic pain.

Robinson-Papp J, Simpson DM.

Pain Med. 2007 Sep;8 Suppl 2:S43-9. Review.

PMID:
17714115
2.

Treating diabetic peripheral neuropathic pain.

Lindsay TJ, Rodgers BC, Savath V, Hettinger K.

Am Fam Physician. 2010 Jul 15;82(2):151-8. Review.

3.

Pregabalin and duloxetine for the treatment of neuropathic pain disorders.

Terneus W.

J Pain Palliat Care Pharmacother. 2007;21(1):79-84.

PMID:
17430838
4.

Diabetic peripheral neuropathic pain: recognition and management.

Cole BE.

Pain Med. 2007 Sep;8 Suppl 2:S27-32. Review.

PMID:
17714113
5.

Clinical inquiry: what medications are best for diabetic neuropathic pain?

Page N, Deluca J, Crowell K.

J Fam Pract. 2012 Nov;61(11):691-3. Review.

PMID:
23256101
6.

Possible drug-drug interaction between adalimumab and duloxetine and/or pregabalin in a psoriasis patient.

Gupta R, Wu JJ, Levin E, Koo JY, Liao W.

J Drugs Dermatol. 2013 Oct;12(10):1089. No abstract available.

PMID:
24085041
7.

A new combination cream for the treatment of severe neuropathic pain.

Kopsky DJ, Keppel Hesselink JM.

J Pain Symptom Manage. 2010 Feb;39(2):e9-e10. doi: 10.1016/j.jpainsymman.2009.09.004. No abstract available.

PMID:
20152584
8.

Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain.

Argoff CE, Backonja MM, Belgrade MJ, Bennett GJ, Clark MR, Cole BE, Fishbain DA, Irving GA, McCarberg BH, McLean MJ.

Mayo Clin Proc. 2006 Apr;81(4 Suppl):S12-25. Review. Erratum in: Mayo Clin Proc. 2006 Jun;81(6):854.

PMID:
16608049
9.

Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?

Russell JW.

Nat Clin Pract Neurol. 2006 Jan;2(1):18-9. No abstract available.

PMID:
16932514
10.

Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.

Zhao Y, Sun P, Watson P.

Curr Med Res Opin. 2011 Apr;27(4):785-92. doi: 10.1185/03007995.2011.554807. Epub 2011 Feb 8.

PMID:
21303196
11.

Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.

Rudroju N, Bansal D, Talakokkula ST, Gudala K, Hota D, Bhansali A, Ghai B.

Pain Physician. 2013 Nov-Dec;16(6):E705-14. Erratum in: Pain Physician. 2014 Mar-Apr;17(2):203.

12.

Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study.

Chen S, Wu N, Boulanger L, Fraser K, Zhao Z, Zhao Y.

J Med Econ. 2011;14(4):411-20. doi: 10.3111/13696998.2011.585676. Epub 2011 May 26.

PMID:
21615268
13.
14.

Treatment of neuropathic pain in patients with chronic kidney disease.

Naylor HK, Raymond CB.

CANNT J. 2011 Jan-Mar;21(1):34-8; quiz 39-40. No abstract available.

PMID:
21561014
15.

Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?

Marchettini P, Wilhelm S, Petto H, Tesfaye S, Tölle T, Bouhassira D, Freynhagen R, Cruccu G, Lledó A, Choy E, Kosek E, Micó JA, Späth M, Skljarevski V, Lenox-Smith A, Perrot S.

Eur J Pain. 2016 Mar;20(3):472-82. doi: 10.1002/ejp.763. Epub 2015 Aug 27.

PMID:
26311228
16.

Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalin.

Matsuoka H, Makimura C, Koyama A, Otsuka M, Okamoto W, Fujisaka Y, Kaneda H, Tsurutani J, Nakagawa K.

Anticancer Res. 2012 May;32(5):1805-9.

PMID:
22593465
17.

Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.

O'Connor AB.

J Pain. 2006 Nov;7(11):867; author reply 867-8. No abstract available.

PMID:
17074629
18.

Duloxetine (Cymbalta) for diabetic neuropathic pain.

[No authors listed]

Med Lett Drugs Ther. 2005 Aug 15-29;47(1215-1216):67-8.

PMID:
16103866
19.

Newer agents for the treatment of painful diabetic peripheral neuropathy.

Freeman R.

Curr Diab Rep. 2005 Dec;5(6):409-16. Review.

PMID:
16316590
20.

Supplemental Content

Support Center